Tex. Gov't Code § 549.0353 · Subchapter H. MEDICAID DRUG UTILIZATION REVIEW PROGRAM
ANNUAL REPORT.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) In addition to any other information required by federal law, the commission shall include the following information in the annual report regarding the Medicaid Drug Utilization Review Program:
(1) a detailed description of the program's activities; and
(2) estimates of cost savings anticipated to result from the program's performance of prospective and retrospective drug use reviews.
(b) The cost-saving estimates for prospective drug use reviews under Subsection (a) must include savings attributed to drug use reviews performed through the vendor drug program's electronic claims processing system and clinical edits screened through the prior authorization system implemented under Subchapter F.
(c) The commission shall post the annual report regarding the Medicaid Drug Utilization Review Program on the commission's Internet website.
Notes and commentary — not statutory text
History
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/GV/htm/GV.549.htm
- Text hash
- sha256 8f09e28057089bd2cd8a763a6ad23743bf0bbece0a01fca27cdc9a57d089cc05
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.